Latinas’ Appraisal of Participation in Breast Cancer Prevention Clinical Trials

Ellington L. , Wahab S. , Sahami S. . Decision-making issues for randomized clinical trial participation among Hispanics. Cancer Control. 2003; 10(suppl);10: 84–86.

Larson E. . Exclusion of certain groups from clinical research. Image J Nurs Sch. 1994; 26: 185–190.

Brown B.A. , Long H.L. , Gould H. . A conceptual model for the recruitment of diverse women into research studies. J Women's Health Gender-Based Med. 2000; 9: 625–632.

US Census Bureau. The Hispanic Population: Census 2000 Brief. Available at: http://www.census.gov/prod/2001pubs/c2kbr01-3.pdf. Accessed July 12,2005.

Holsti O.R. . Content Analysis for the Social Sciences. Reading, Mass: Addison-Wesley; 1969.

Krippendorf K. . Content Analysis: An Introduction to Its Methodology. Beverly Hills, Calif: Sage Publications; 1980.

Borrayo E.A. , Jenkins S.R. . Feeling indecent: breast cancer screening resistance of Mexican-descent women. J Health Psychol. 2001; 6: 537–550.

Murthy V.H. , Krumholz H.M. , Gross C.P. . Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004; 291: 2720–2726.

Swanson G.M. , Bailar JC 3rd . Selection and description of cancer clinical trials participants: science or happenstance? Cancer. 2002; 95: 950–959.

Fisher B. , Costantino J.P. , Wickerham D.L. . Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998; 90: 1371–1388.